Assessing the Merits of a PPI Trial-Based Diagnosis for Gastroesophageal Reflux Disease: Speculations on Efficacy and Pitfalls
2021 ◽
pp. 263451612110249
Keyword(s):
Gastroesophageal reflux disease is a highly prevalent condition which can lead to complications in affected individuals. Given the economic implications of widespread testing, there has been interest in a symptom-based approach to diagnosis and use of short-term empiric acid suppressive therapy as a diagnostic modality. This review will highlight the background with regards to these clinical questions, the data regarding performance characteristics of establishing a symptom-based reflux diagnosis (focusing on typical, atypical, and extra-esophageal symptoms), the merits of the so-called “PPI Trial” and potential pitfalls to consider when seeing patients with suspected reflux symptoms.
2014 ◽
Vol 109
◽
pp. S17
2019 ◽
Vol 26
(19)
◽
pp. 3497-3511
◽
2004 ◽
Vol 99
(6)
◽
pp. 991-996
◽
2012 ◽
Vol 24
(5)
◽
pp. 446-450
◽
2018 ◽
Vol 55
(3)
◽
pp. 296-305
◽
2018 ◽
Vol 55
(suppl 1)
◽
pp. 52-55
◽
2020 ◽
Vol 85
(1)
◽
pp. 4-11
2011 ◽
Vol 106
◽
pp. S4